1 – 15 of 28
- show: 15
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Disruption of the TP53 locus in osteosarcoma leads to TP53 promoter gene fusions and restoration of parts of the TP53 signalling pathway
(
- Contribution to journal › Article
-
Mark
Osteosarcomas With Few Chromosomal Alterations or Adult Onset Are Genetically Heterogeneous
(
- Contribution to journal › Article
- 2022
-
Mark
Hydroxyapatite – A trojan horse in the delivery of apatite-binding cytostatics in bone cancer
2022) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
SELNET clinical practice guidelines for bone sarcoma
(
- Contribution to journal › Article
-
Mark
Longitudinal in vivo biodistribution of nano and micro sized hydroxyapatite particles implanted in a bone defect
(
- Contribution to journal › Article
-
Mark
Intralesional margin after excision of a high-grade osteosarcoma : Is it a catastrophe?
(
- Contribution to journal › Article
-
Mark
Bone mineral : A trojan horse for bone cancers. Efficient mitochondria targeted delivery and tumor eradication with nano hydroxyapatite containing doxorubicin
(
- Contribution to journal › Article
- 2021
-
Mark
Sustained and controlled delivery of doxorubicin from an in-situ setting biphasic hydroxyapatite carrier for local treatment of a highly proliferative human osteosarcoma
(
- Contribution to journal › Article
- 2020
-
Mark
Loss of NF2 defines a genetic subgroup of non-FOS-rearranged osteoblastoma
(
- Contribution to journal › Article
-
Mark
NTRK fusions in osteosarcoma are rare and non-functional events
(
- Contribution to journal › Article
- 2019
-
Mark
Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort
(
- Contribution to journal › Article
-
Mark
Quality of life of patients with osteosarcoma in the european american osteosarcoma study-1 (EURAMOS-1) : Development and implementation of a questionnaire substudy
(
- Contribution to journal › Article
- 2018
-
Mark
EURO-B.O.S.S. : A European study on chemotherapy in bone-sarcoma patients aged over 40: Outcome in primary high-grade osteosarcoma
(
- Contribution to journal › Article
- 2016
-
Mark
Severe gonadotoxic insult manifests early in young girls treated for Ewing sarcoma
(
- Contribution to journal › Article
- 2014
-
Mark
High-Dose Chemotherapy with Stem Cell Rescue in the Primary Treatment of Metastatic and Pelvic Osteosarcoma: Final Results of the ISG/SSG II Study
(
- Contribution to journal › Article